Doctor Wen Sun
The Chinese University of Hong Kong, Shatin (Hong Kong)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Atrial Fibrillation (AF) detected by repeat handheld ECG screening and the risk of heart failure hospitalization
Event: ESC Congress 2024
Topic: Heart Failure in Atrial Fibrillation
Session: The interplay between atrial fibrillation and heart failure: implications for clinicians
Resumption of anticoagulation therapy among Non-Valvular Atrial Fibrillation (NVAF) patients with prior intracranial haemorrhage
Event: ESC Congress 2024
Topic: Oral Anticoagulation
Session: Clinical decision-making about oral anticoagulant therapy in atrial fibrillation
Screening for Atrial Fibrillation (AF) by handheld single-lead ECG and risk of all-cause mortality stratified by non-AF cardiovascular disease
Event: ESC Congress 2024
Topic: Sudden Death in Patients with Atrial Fibrillation
Session: Atrial fibrillation: what is associated with mortality?
Impact of resumption of Oral AntiCoagulation therapy (OAC) after GastroIntestinal Bleeding (GIB) on clinical outcomes in patients with Non-Valvular Atrial Fibrillation (NVAF)
Event: ESC Congress 2024
Topic: Oral Anticoagulation
Session: Oral anticoagulant therapy for atrial fibrillation in clinical practice
10-year trends in oral anticoagulation therapies and ischemic stroke among 157,583 patients with non-valvular atrial fibrillation
Event: ESC Congress 2023
Topic: Stroke in Atrial Fibrillation
Session: Stroke prediction and prevention in atrial fibrillation
Atrial fibrillation burden and timing of anticoagulation therapy in patients with screen-detected and clinically-diagnosed AF
Event: ESC Congress 2023
Topic: Stroke in Atrial Fibrillation
Session: Stroke prediction and prevention in atrial fibrillation
Impact of sodium-glucose co-transporter 2 inhibitors on cardiovascular outcomes in patients with chronic kidney disease: Hong Kong-wide, observational, propensity score matched analysis
Event: ESC Congress 2022
Topic: Renal Failure and Cardiovascular Disease
Session: Renal failure and cardiovascular disease 1
Timing of initiation of sodium-glucose co-transporter 2 inhibitor in patients with diabetes and chronic cardiac failure
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Chronic heart failure and diabetes
Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Can we improve outcomes by targeting metabolic risk?
Potential benefits of ticagrelor plus aspirin in Chinese patients with stable coronary artery disease and diabetes
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
